Viewing data from:

BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE

ANDA

BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE | A075672 | ACTAVIS ELIZABETH LLC

3 strengths0 unique patents0 unique exclusivities

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
May 28, 2004	ORIG -1	View Letter (PDF)
Sep 25, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 2.5MG;6.25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Sep 25, 2000

No patent or exclusivity listings for this strength.

#002 — 5MG;6.25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 25, 2000

#003 — 10MG;6.25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Sep 25, 2000